There are 14 studies


Meridian, ID
(208) 643-8325

Alzheimer’s with Agitation Clinical Research Study

If your loved one has been diagnosed with Alzheimer’s Disease and is experiencing agitation symptoms, the ADVANCE study may be an option.

To pre-qualify, your loved one must:
- Be between 65 and 90 years of age
- Have a diagnosis of Alzheimer’s Disease with agitation
- Meet other study criteria

Qualified participants will receive:
- Study-related medication and exams at no cost
- Compensation for time and travel

To learn more about this research study, call ACR

Learn More


Lake City, FL
(386) 516-4120


A clinical research study evaluating an investigational drug for agitation associated with Alzheimer's disease is now recruiting participants who:
- Are between 65 and 90 years of age
- Are experiencing agitation associated with Alzheimer's disease

Eligible patients will receive study-related care and treatment with either the study drug or the placebo for five weeks. Compensation for time and travel may be available to patients and caregivers. Contact the participating doctor below to learn more.

Guy Strauss, DO
Multi-Specialty Research Associates, Inc.

4551 West US 90, Suite 101
Lake City, FL 32055

Learn More


Oceanside, CA
(760) 990-1884

Are you concerned about your memory?

Excell Research is conducting a Phase 3 Clinical Trial in patients with mild memory problems. This research is being done to determine whether an investigational drug known as AGB101 will slow any progression of mild cognitive impairment (MCI), a condition that increases risk for Alzheimer’s Disease.

You may be eligible if you:
- Have recent memory changes or received a diagnosis of mild cognitive impairment (MCI)
- Are between 55-85 years old

Participation includes:
- Up to 3 screening visits; If eligible, up to 7 clinic visits over 18 months

- Take tests of memory, thinking skills, daily functioning and behavior
- Have Positron Emission Tomography (PET) scans of your brain
- Have 3.0 Tesla Magnetic Resonance Imaging (3T MRI) scans of your brain
- Give blood and urine samples
- Taking either AGB101 or placebo capsule once a day for a period of 18 months
- Compensation of up to $750.00 for your time

For more information, contact:
Excell Research, Inc.

Principal Investigator: Sherry A. Soefje, MD
Protocol #: AGB101MCD
Sponsor: National Institutes of Aging & AgeneBio, inc.

Learn More


West Long Branch, NJ
(732) 945-8870

Did you know that bacteria associated with gum disease may cause Alzheimer’s?

Even if you have no symptoms of gum disease, you may still be at risk. Consider joining a new clinical trial evaluating whether an investigational drug is safe and can halt the progression of Alzheimer’s disease by reducing the damage caused by oral bacteria that travel to the brain.

You or a loved one may be eligible for the study if you:
- Are 55 to 80 years old
- Have been diagnosed with mild to moderate Alzheimer’s disease
- Have a caregiver who will attend study visits

Study participation, testing and medication are free to all subjects. Some people may receive stipends to cover meals and travel related to study visits.

To find out about participating, contact:
Neurology Specialists of Monmouth County
107 Monmouth Road Suite 110,
West Long Branch, NJ 07764

Learn More


Gilbert, Arizona
(480) 725-6113

Agitation Associated with Alzheimer’s Dementia Affects the Whole Family:

Do you know the signs to look for?

What is Agitation Associated with ALZHEIMER’S DEMENTIA?
Patients diagnosed with Alzheimer's dementia are known to have memory problems. Less well known is that some patients with Alzheimer's dementia may also have certain behavioral changes called agitation. These behaviors can be very disturbing for patients and their loved ones. Examples of some easily identified agitated behaviors are: restlessness, pacing and aimless wandering, screaming, tearing things or destroying property, shouting, hitting others or self, throwing things, pushing people, resistiveness, hurting self or others, constant unwarranted requests for attention or help, and kicking. Do any of these behavioral changes describe you or your loved one? Patients showing signs of agitated behavior may be eligible to enroll in the TRIAD Research Study.

What is the TRIAD Research Study?
The TRIAD Research Study is evaluating an investigational drug (also called the study drug) to determine if it might reduce the symptoms of agitation associated with Alzheimer’s dementia, as well as testing its safety and tolerability in participants.

- Be 50 to 90 years old
- Have moderate to severe agitation associated with Alzheimer’s dementia
- Have a carer who can attend all study visits

Additional criteria for eligibility will apply. Study participants receive study-related medical exams and study drug at no cost. Reimbursement for time and travel may be available.

To learn more about the TRIAD Research Study and agitation associated with Alzheimer’s dementia, or to see if your loved one may qualify:
LivGenerations Agritopia

Learn More


Fullerton, CA
(714) 477-7339

Are you and your loved one a good fit for this study?

If you’re interested in taking part in the GRADUATE II study, you will be assessed carefully by the study team to confirm if the study is right for you. You may be able to take part if you:

- Are 50-90 years old
- Have mild Alzheimer’s disease or memory problems that may be the early symptoms of Alzheimer’s disease
- Have someone you see frequently who will be your Study Partner and can:

– Attend clinic visits with you when necessary
– Be available to answer questions about your symptoms and any changes they may notice
– Provide accurate information about how you are feeling

Learn More